drugset / Trial / NCT04948788
SHR1459 in Combination With YY-20394 in Recurrent and Refractory B-cell Non-Hodgkin's Lymphoma
RandomizedParallel-groupOpen-labelTreatment
Summary
The study is evaluating the efficacy, and safety of SHR1459 combined with YY-20394 for Recurrent and refractory B-cell non-Hodgkin's lymphoma in adults.
Timeline
- Start
- 2021-10
- Primary completion
- 2023-04
- Completion
- 2023-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EDRALBRUTINIB | Small molecule | — | — |
| Subject | Gemcitabine | Small molecule | — | — |
| Subject | Linperlisib | Small molecule | — | — |
| Subject | Oxaliplatin | Small molecule | — | — |